Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003651 |
---|---|
Receipt number | R000004420 |
Scientific Title | A Randomized Phase III Trial of Adjuvant Chemotherapy with UFT following Curative Radiation Therapy for Locally Advanced Cervical Cancer |
Date of disclosure of the study information | 2010/05/24 |
Last modified on | 2023/05/31 15:00:21 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/05/21 16:57:34 | ||
2 | Update | 2010/11/22 10:13:19 | Institutions |
|
3 | Update | 2011/05/23 11:41:14 | Institutions |
|
4 | Update | 2011/11/21 10:44:27 | Post marketing survey by drug manufacture etc., specified by Japanese law. Institutions |
|
5 | Update | 2012/05/21 11:14:37 | Institutions |
|
6 | Update | 2012/05/21 11:16:30 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
7 | Update | 2012/11/21 09:57:53 | Institutions |
|
8 | Update | 2013/05/21 11:10:20 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
9 | Update | 2013/05/21 11:18:39 | Division name Division name Institutions |
|
10 | Update | 2013/05/21 11:19:47 | Target sample size |
|
11 | Update | 2013/06/21 11:22:37 | Organization1 Email1 Institutions |
|
12 | Update | 2013/11/21 10:41:51 | Email Institutions |
|
13 | Update | 2014/05/21 09:43:49 | Institutions |
|
14 | Update | 2014/11/21 10:05:02 | Institutions |
|
15 | Update | 2015/05/21 14:32:10 | Name of person sending information Name of person sending information Institutions |
|
16 | Update | 2015/11/25 15:39:07 | Randomization unit Target sample size |
|
17 | Update | 2015/11/25 16:29:21 | Name of person sending information Institutions |
|
18 | Update | 2015/11/25 16:31:10 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
19 | Update | 2016/05/24 09:22:40 | Name of primary person or sponsor Organization Institutions |
|
20 | Update | 2017/05/25 10:29:46 | Institutions |
|
21 | Update | 2017/05/25 10:30:58 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
22 | Update | 2018/05/28 09:53:33 | Institutions |
|
23 | Update | 2018/09/27 11:30:25 | Institutions |
|
24 | Update | 2018/09/27 11:31:10 | Recruitment status |
|
25 | Update | 2018/09/27 11:46:18 | Division name Division name |
|
26 | Update | 2018/10/10 14:38:41 | Name of person sending information Name of person sending information |
|
27 | Update | 2019/03/22 17:29:59 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address Last name of contact person Last name of contact person Zip code Address Address Organization Organization Address Address Tel |
|
28 | Update | 2019/03/22 17:36:57 | Institutions |
|
29 | Update | 2019/05/30 11:07:14 | Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
30 | Update | 2020/05/27 11:59:23 | Institutions |
|
31 | Update | 2023/01/12 12:13:27 | Date of IRB Anticipated trial start date Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
32 | Update | 2023/05/31 15:00:21 | Address Institute Organization |